Skip to main content
. 2017 May 31;69(9):1145–1154. doi: 10.1111/jphp.12752

Table 1.

Study designs

Experiment Dosing schedule Dosage (mg/kg per week) Dosage (mg/kg per time) Treated days after the first immunization (efficacy) or Treated days (Toxicity) Number of mice Observations
1–1 Control 0 0 8–14 12 Arthritis score (Figure 1)
Once weekly 7 7 8 12
Thrice weekly 7 2.33 8 (twice daily), 9 12
Once daily (1.0 mg/kg) 7 1 8–14 12
1–2 Control 0 0 1–21 6 Arthritis score (Figure 2)
Once weekly 7 7 1, 8, 15 6
Thrice weekly 7 2.33 1 (twice daily), 2 8 (twice daily), 9 15 (twice daily), 16 6
Once daily (1.0 mg/kg) 7 1 1–21 6
2 Control 0 0 1–21 18 Arthritis score (Figure 3)
Once weekly 7 7 1, 8, 15 6
Thrice weekly 7 2.33 1 (twice daily), 2 8 (twice daily), 9 15 (twice daily), 16 18
Once daily (0.1 mg/kg) 0.7 0.1 1–21 6
Once daily (0.25 mg/kg) 1.75 0.25 1–21 6
Once daily (0.5 mg/kg) 3.5 0.5 1–21 6
Once daily (1.0 mg/kg) 7 7 1–21 6
3 Normal 0 0 1–21 6 Type II collagen antibody (Figure 4)
CIA 0 0 1–21 6
Thrice weekly 7 2.33 1 (twice daily), 2 8 (twice daily), 9 15 (twice daily), 16 6
Once daily (0.25 mg/kg) 1.75 0.25 1–21 6
Once daily (1.0 mg/kg) 7 7 1–21 6
4 Control 0 0 0–20 6 WBC counts (Figure 5) ALT and BUN levels (Table 2)
Thrice weekly 7 2.33 0–20 6
Once daily (0.25 mg/kg) 1.75 0.25 0 (twice daily), 1 7 (twice daily), 8 14 (twice daily), 15 6
Once daily (1.0 mg/kg) 7 7 0–20 6